WINNIPEG, Manitoba - (January 9, 2002) - Medicure Inc. (TSX:
MPH), a cardiovascular drug discovery and development company is
pleased to announce that it will host a Conference Call on Tuesday,
January 14, 2003, to discuss its recently concluded MEND-1 Phase
II clinical study, which was managed by the Duke Clinical Research
Institute in Durham, North Carolina.
A News Release will be issued in the morning of January 14, 2003,
with the Conference Call taking place at 3 p.m. Eastern Standard
Time.
Participating in the Conference Call from Medicure's senior management
group will be Dr. Albert D. Friesen, PhD., Chairman and Chief Executive
Officer, Derek Reimer, Chief Financial Officer, Dawson Reimer, Director
of Business Development and Dr. Karl-Gunnar Hidinger, Vice-President,
Clinical Development. Also taking part in the call will be Dr. Robert
Harrington, Director, Cardiovascular Clinical Trials at the Duke
Clinical Research Institute, Duke University in Durham, North Carolina,
The Conference Call will feature presentations by Drs. Friesen,
Harrington and Hidinger, and will be followed by a question and
answer session.
SUMMARY
Date of Conference Call: Tuesday, January 14, 2003
Time of Call: 3 p.m. Eastern Standard Time
Dial-in Numbers for 1-800-461-2816 (Toll Free)
Participants 416-695-5261 (Toronto area participants)
About Medicure Inc.
Medicure Inc. is a cardiovascular drug discovery and development
Company focused on developing effective therapeutics for unmet needs
in the field of cardiovascular medicine including the prevention
and treatment of ischemia, ischemic reperfusion injury, and stroke.
This press release contains forward-looking statements that involve
risks, which may cause actual results to differ materially from
the statements made, and accordingly may be deemed to be forward-looking
statements made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. The forward-looking statements
are made as of the date hereof, and the Company disclaims any intention
and has no obligation or responsibility to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise.
For more information, please contact:
Derek Reimer
Chief Financial Officer
Medicure Inc.
888-435-2220
204-488-9823
faxinfo@medicure.com
